Volume 63, Issue 6, Pages (June 2003)

Slides:



Advertisements
Similar presentations
Volume 56, Issue 5, Pages (November 1999)
Advertisements

Takehiko Wada, Jeffrey W. Pippin, Yoshio Terada, Stuart J. Shankland 
High Glucose-Induced Hypertrophy of Mesangial Cells Requires p27Kip1, an Inhibitor of Cyclin-Dependent Kinases  Gunter Wolf, Regine Schroeder, Gunther.
Volume 68, Issue 4, Pages (October 2005)
Volume 70, Issue 8, Pages (October 2006)
Volume 131, Issue 4, Pages (October 2006)
Volume 6, Issue 5, Pages (November 2004)
UVB Increases Urokinase-Type Plasminogen Activator Receptor (uPAR) Expression1  Christoph Marschall, Toshiko Nobutoh, Evelyn Braungart, Kathrin Douwes,
A novel SHP-1/Grb2–dependent mechanism of negative regulation of cytokine-receptor signaling: contribution of SHP-1 C-terminal tyrosines in cytokine signaling.
Yoshihisa Ishikawa, Masanori Kitamura  Kidney International 
Canonical Wnt/β-catenin signaling mediates transforming growth factor-β1-driven podocyte injury and proteinuria  Dan Wang, Chunsun Dai, Yingjian Li, Youhua.
Volume 56, Issue 4, Pages (October 1999)
Roles of the cytoplasmic domains of the α and β subunits of human granulocyte- macrophage colony-stimulating factor receptor  Akihiko Muto, PhDa, Sumiko.
Large Hepatitis Delta Antigen Modulates Transforming Growth Factor-β Signaling Cascades: Implication of Hepatitis Delta Virus–Induced Liver Fibrosis 
Volume 62, Issue 3, Pages (September 2002)
Differential influence of tyrosine residues of the common receptor β subunit on multiple signals induced by human GM-CSF  Tohru Itoh, PhD, Rui Liu, MSc,
Volume 60, Issue 1, Pages (July 2001)
Volume 66, Issue 5, Pages (November 2004)
Volume 131, Issue 4, Pages (October 2006)
IFN-γ Upregulates Expression of the Mouse Complement C1rA Gene in Keratinocytes via IFN-Regulatory Factor-1  Sung June Byun, Ik-Soo Jeon, Hyangkyu Lee,
Volume 60, Issue 2, Pages (August 2001)
Volume 116, Issue 5, Pages (May 1999)
Volume 62, Issue 4, Pages (October 2002)
Volume 56, Issue 5, Pages (November 1999)
TGF-β isoforms in renal fibrogenesis
Transcriptional activation of transforming growth factor-β1 in mesangial cell culture by high glucose concentration  Brenda B. Hoffman, Kumar Sharma,
Volume 64, Issue 5, Pages (November 2003)
Volume 69, Issue 3, Pages (February 2006)
Volume 68, Issue 3, Pages (September 2005)
Andreea M. Bujor, Jaspreet Pannu, Shizhong Bu, Edwin A. Smith, Robin C
IGF-II-Mediated COX-2 Gene Expression in Human Keratinocytes Through Extracellular Signal-Regulated Kinase Pathway  Hye Jung Kim, Tae-Yoon Kim  Journal.
Yongli Bai, Chun Yang, Kathrin Hu, Chris Elly, Yun-Cai Liu 
Volume 62, Issue 3, Pages (September 2002)
Volume 68, Issue 1, Pages (July 2005)
Evidence for low-density lipoprotein–induced expression of connective tissue growth factor in mesangial cells  Mimi Sohn, Yan Tan, Richard L. Klein, Ayad.
Volume 65, Issue 6, Pages (June 2004)
Cell-Density-Dependent Regulation of Expression and Glycosylation of Dopachrome Tautomerase/Tyrosinase-Related Protein-2  Thomas J. Hornyak, Daniel J.
Role of p38 MAPK in Transforming Growth Factor β Stimulation of Collagen Production by Scleroderma and Healthy Dermal Fibroblasts  Madoka Sato, Daniel.
Volume 68, Issue 4, Pages (October 2005)
Volume 54, Issue 1, Pages (July 1998)
Stimulation of Type I Collagen Transcription in Human Skin Fibroblasts by TGF-β: Involvement of Smad 3  Shu-Jen Chen, Weihua Yuan, Yasuji Mori, Anait.
1,25-dihydroxyvitamin D3 inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression  Yingjian Li, Bradley C.
Hypoxia promotes fibrogenesis in human renal fibroblasts
Volume 53, Issue 6, Pages (June 1998)
Upregulation of Tenascin-C Expression by IL-13 in Human Dermal Fibroblasts via the Phosphoinositide 3-kinase/Akt and the Protein Kinase C Signaling Pathways 
Volume 60, Issue 3, Pages (September 2001)
Volume 60, Issue 6, Pages (December 2001)
Ketoconazole Suppresses Prostaglandin E2-Induced Cyclooxygenase-2 Expression in Human Epidermoid Carcinoma A-431 Cells  Naoko Kanda, Dr., Shinichi Watanabe 
Keratinocyte growth factor promotes goblet cell differentiation through regulation of goblet cell silencer inhibitor  Dai Iwakiri, Daniel K. Podolsky 
P. Harding, L. Balasubramanian, J. Swegan, A. Stevens, W.F. Glass 
Halofuginone, an Inhibitor of Type-I Collagen Synthesis and Skin Sclerosis, Blocks Transforming-Growth-Factor-β-Mediated Smad3 Activation in Fibroblasts 
Izabella Z.A. Pawluczyk, Kevin P.G. Harris  Kidney International 
Volume 61, Issue 6, Pages (June 2002)
Volume 85, Issue 2, Pages (January 2014)
Roles of the cytoplasmic domains of the α and β subunits of human granulocyte- macrophage colony-stimulating factor receptor  Akihiko Muto, PhDa, Sumiko.
Volume 55, Issue 5, Pages (May 1999)
Volume 62, Issue 4, Pages (October 2002)
Jens Gaedeke, Nancy A. Noble, Wayne A. Border  Kidney International 
Volume 64, Issue 6, Pages (December 2003)
Volume 57, Issue 2, Pages (October 2000)
Ken Inoki, Masakazu Haneda, Shiro Maeda, Daisuke Koya, Ryuichi Kikkawa 
Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue- type plasminogen activator  Thomas Sitter, Karin Toet, Paul.
Sequential effects of high glucose on mesangial cell transforming growth factor-β1 and fibronectin synthesis  Jong Hoon Oh, Hunjoo Ha, Mi Ra Yu, Hi Bahl.
Volume 70, Issue 8, Pages (October 2006)
Volume 60, Issue 6, Pages (December 2001)
Volume 4, Issue 4, Pages (October 1999)
Volume 59, Issue 2, Pages (February 2001)
Effects of Hepatocyte Growth Factor on the Expression of Type I Collagen and Matrix Metalloproteinase-1 in Normal and Scleroderma Dermal Fibroblasts 
A Smad Transcriptional Corepressor
Suppression of Keratinocyte Growth and Differentiation by Transforming Growth Factor β1 Involves Multiple Signaling Pathways  Alison L. Dahler, Lois L.
Presentation transcript:

Volume 63, Issue 6, Pages 2000-2009 (June 2003) Role of Smad4 on TGF-β–induced extracellular matrix stimulation in mesangial cells  Ken-Ichi Tsuchida, Yanqing Zhu, Senthuran Siva, Stephen R. Dunn, Kumar Sharma  Kidney International  Volume 63, Issue 6, Pages 2000-2009 (June 2003) DOI: 10.1046/j.1523-1755.2003.00009.x Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 1 Stable expression of Smad4ΔM4 and Smad4N4 mutant proteins in murine mesangial cells (MMC). A schematic representation of Smad4 deletion constructs based on the known sequence homology domains of the Smad family of proteins (A). MH1 and MH2 domains that are conserved between Smads are shown, respectively. This schema is adapted from17. MMC were transfected with Smad4ΔM4 and Smad4N4 followed by selection in 800 μg/mL of geneticin. To demonstrate the expression of Flag-tagged Smad4 dominant-negative constructs, 20 μg of total cellular protein was resolved on 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gels, transferred to nitrocellulose membrane, and subjected to Western analysis using antibody for Smad4 (B) and the Flag epitope (C). The position of Flag-tagged Smad4 dominant-negative proteins are indicated by the arrow. WT is wild-type. Kidney International 2003 63, 2000-2009DOI: (10.1046/j.1523-1755.2003.00009.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 2 Expression of Smad4ΔM4 and Smad4N4 proteins abolished transforming growth factor-β (TGF-β) stimulated transcriptional response. Wild-type murine mesangial cells (MMC) and MMC stably transfected with Smad4ΔM4 and Smad4N4 constructs were cotransfected transiently with 1 μg of p3TP-Lux and 0.5 μg of pcDNA3.1-LacZ as described in the Methods section. After 24 hours of starvation, cells were incubated in the absence (□) or presence of TGF-β1 (10 ng/mL) (■) for an additional 24 hours. Cells were lysed and luciferase activity was determined using the Promega's Luciferase Assay System according to the manufacturer's instructions. Luciferase activity is expressed as the ratio of specific luciferase activity divided by the β-galactosidase activity of the cotransfected vector. Data are shown as the mean ± SEM of triplicates from three separate experiments. Wild-type MMC without TGF-β at time 0 is arbitrarily set as 1. *P < 0.05 vs. wild-type without TGF-β1; **P < 0.05 vs. wild-type with TGF-β1. Kidney International 2003 63, 2000-2009DOI: (10.1046/j.1523-1755.2003.00009.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 3 The expression of α1 type I collagen (COL1A1) is dependent on Smad4. (A) Representative Northern blot analysis of COL1A1 expression in total RNA lysates from murine mesangial cells (MMC) [wild-type (WT)], Smad4ΔM4 (ΔM4), and Smad4N4 (N4) dominant-negative cell lines exposed to 5 ng/mL of transforming growth factor-β1 (TGF-β1) for the indicated time periods. The membranes were stripped and reprobed for 18S RNA levels to normalize for RNA loading. (B) Quantitative data show the relative expression levels of COL1A1 measured by densitometry after normalization for 18S from three independent experiments. Bar graphs are shown as mean ± SEM expressed relative to the expression in untreated wild-type MMC. Wild-type MMC without TGF-β at time 0 is arbitrarily set as 1. Symbols are: (□), -TGF-β; and (■), +TGF-β. *P < 0.05; **P < 0.01 vs. wild-type at time 0; #P < 0.05; ##P < 0.01 vs. wild-type without TGF-β1 at 24 hours; ‡P < 0.05; ‡‡P < 0.01 vs. wild-type without TGF-β1 at 48 hours. N.S. is not significant. Kidney International 2003 63, 2000-2009DOI: (10.1046/j.1523-1755.2003.00009.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 4 The early, but not sustained, plasminogen activator inhibitor-1 (PAI-1) stimulation by transforming growth factor-β (TGF-β) is partly dependent on Smad4. (A) Representative Northern blot analysis of PAI-1 mRNA expression in total RNA lysates from murine mesangial cells (MMC) [wild-type (WT)], Smad4ΔM4 (ΔM4), and Smad4N4 (N4) dominant-negative cell lines exposed to 5 ng/mL of TGF-β1 for the indicated time periods. (B) Bar graph shows the relative expression level of PAI-1 mRNA measured by densitometry after normalization for 18S from three independent experiments. Data are shown as mean ± SEM expressed relative to the expression in untreated wild-type MMC. Wild-type MMC without TGF-β at time 0 is arbitrarily set as 1. Symbols are: (□), -TGF-β; and (■), +TGF-β. *P < 0.05; **P < 0.005 vs. without TGF-β1; #P < 0.05; ##P < 0.001 vs. wild-type with TGF-β1 at 2 hours; ‡P < 0.005 vs. wild-type with TGF-β1 at 4 hours. Kidney International 2003 63, 2000-2009DOI: (10.1046/j.1523-1755.2003.00009.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 5 Smad4 dominant-negative cells have suppression of α1 type I collagen (COL1A1) (A) but no effect on delayed stimulation of plasminogen activator inhibitor-1 (PAI-1) (B) in mixed clones. Pooled clones of Smad4ΔM4 (ΔM4) and Smad4N4 (N4) stably transfected cells were assessed for basal and transforming growth factor-β1 (TGF-β1)–stimulated expression of COL1A1 and PAI-1. Murine mesangial cells (MMC) with stable transfection with an empty vector were used as control. Similar to data shown in Figures 3 and 4, there is marked inhibition of basal and TGF-β–stimulated levels of COL1A1 at 24 hours and 48 hours in Smad4 dominant-negative cells. Basal levels of PAI-1 are not affected in Smad4 dominant-negative cells and there is no decrease in TGF-β1 stimulation of PAI-1 at 24 hours and 48 hours. The data show the relative expression levels of COL1A1 measured by phosphoimager after normalization for 18S from three independent experiments. Bar graphs are shown as mean ± SEM expressed relative to the expression in untreated MMC. Empty vector transfected MMC without TGF-β (Control) is arbitrarily set as 1. *P < 0.05 vs. control. Kidney International 2003 63, 2000-2009DOI: (10.1046/j.1523-1755.2003.00009.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 6 The effect of early stimulation by transforming growth factor-β1 (TGF-β1) on α1 type I collagen (COL1A1) (A) and plasminogen activator inhibitor-1 (PAI-1) (B) expression in empty vector and mixed clones of Smad4 dominant-negative cells. TGF-β1 has no effect on COL1A1 at the early time points tested. As noted previously, basal levels of COL1A1 are suppressed in pooled clones of Smad4ΔM4 and SmadN4 stably transfected cells at these time points. TGF-β1 markedly stimulates PAI-1 at the early time points, whereas there is a reduction of PAI-1 stimulation in the pooled clones of Smad4ΔM4 and SmadN4 stably transfected cells. The data show the relative expression levels of COL1A1 and PAI-1 measured by phosphoimager after normalization for 18S from three independent experiments. Bar graphs are shown as mean ± SEM expressed relative to the expression in untreated murine mesangial cells (MMC). Empty vector transfected MMC without TGF-β (Control) is arbitrarily set as 1. *P < 0.05 vs. control. Kidney International 2003 63, 2000-2009DOI: (10.1046/j.1523-1755.2003.00009.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 7 Transforming growth factor-β (TGF-β)–induced fibronectin expression of fibronectin is independent of Smad4. (A) Representative Northern blot analysis of fibronectin in murine mesangial cells (MMC) [wild-type (WT)], Smad4ΔM4 (ΔM4) and Smad4N4 (N4) dominant-negative cell lines exposed to 5 ng/mL of TGF-β1 for the indicated time periods. Total RNA (15 μg) was electrophoresed, transferred onto nylon membrane, and probed with a murine probe for fibronectin. The membranes were stripped and reprobed for 18S rRNA levels to normalize for RNA loading. (B) Bar graph shows the relative expression level of fibronectin mRNA measured by densitometry after normalization for 18S. Data are shown as mean ± SEM from three independent experiments and expressed relative to the expression in untreated wild-type MMC. Wild-type MMC without TGF-β at time 0 is arbitrarily set as 1. Symbols are: (□), -TGF-β; and (■), +TGF-β. *P < 0.05 vs. without TGF-β1. Kidney International 2003 63, 2000-2009DOI: (10.1046/j.1523-1755.2003.00009.x) Copyright © 2003 International Society of Nephrology Terms and Conditions